Drug · DIN 02566087
NRA-RISPERIDONE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since February 24, 2026.
- Drug Identification Number (DIN)
- 02566087
- Company (DIN owner)
- Nora Pharma Inc.Varennes, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- February 27, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 4 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 24, 2026: NOC 36962Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
Other DINs named NRA-RISPERIDONE
- DIN 02565994 · Approved
- DIN 02566028 · Approved
- DIN 02566036 · Approved
- DIN 02566044 · Approved
- DIN 02566060 · Approved